(Bloomberg) -- Medical device makers are among companies with the biggest potential for stock gains after the Republicans prevailed in midterm U.S. elections.

Boston Scientific Corp. is poised to climb with Republican victories in the Senate amid speculation the party will seek to repeal an excise tax on pacemakers and defibrillators, said Dan Clifton, head of policy research at Strategas Research Partners in Washington.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access